New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 25, 2014
08:47 EDTSRNESorrento Therapeutics and Morphotek sign drug development agreement
Sorrento Therapeutics subsidiary Concortis Biosystems announced a collaboration to generate novel antibody drug conjugates based on a Morphotek antibody linked to chemotherapeutic agents using Concortis' proprietary ADC Technology. Under the terms of the agreement, Sorrento will receive research fees, up-front payment, milestone payments and royalties on future net sales. Sorrento has the potential to receive up to $50M upon successful attainment of key milestones.
News For SRNE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 19, 2015
07:35 EDTSRNEAdvaxis, Sorrento Therapeutics form collaboration
Subscribe for More Information
May 18, 2015
09:01 EDTSRNESorrento Therapeutics establishes TNK Therapeutics subsidiary
Subscribe for More Information
May 15, 2015
16:17 EDTSRNEOn The Fly: Top stock stories for Friday
Subscribe for More Information
13:01 EDTSRNEOn The Fly: Top stock stories at midday
Subscribe for More Information
12:26 EDTSRNESorrento deal 'huge validation' of potential, says H.C. Wainwright
H.C. Wainwright views NantWorks' acquisition of Sorrento's Cynviloq as "huge validation" of the drug's potential. The firm notes NantWorks is owned by Dr. Patrick Soon-Shiong, who previously launched Abraxane. The firm reiterates a Buy rating on Sorrento with a $20 price target.
09:51 EDTSRNESorrento Therapeutics resumes, up 23% after announcing deal for Cynviloq rights
Subscribe for More Information
09:11 EDTSRNESorrento Therapeutics to resume trading at 9:50 am EDT
Subscribe for More Information
09:02 EDTSRNENantWorks acquires rights to Cynviloq
Subscribe for More Information
08:59 EDTSRNESorrento Therapeutics trading halted, pending news
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use